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Previewscomposition on short-term synaptic plas-
ticity, how such changes might affect
long-term forms of synaptic plasticity
and activity in local networks remains
untested.
Penn et al. (2012), take a rigorous
approach to address the composition of
AMPAR complexes at synapses. There
remain however great challenges in
relating molecular events inside the cell
to synaptic outcomes. Numerous genetic
and optical approaches are needed to
address the subunit-specific composition
of receptor complexes not only at
synapses but also within the biosynthetic
and secretory pathways. Optical ap-
proaches aimed at determining subunit
composition of synaptic iGluRs are being
developed. For example, the use of single
particle tracking photoactivation localiza-
tion microscopy in concert with viral
glycoproteins has begun to redefine our
understanding of membrane receptor
dynamics and their movement trajecto-
ries within the cell (Hoze et al., 2012).
However, these techniques at present
do not allow subunit/splice variant
composition of AMPARs to be defined.
Development of quantitative imaging and
biochemical techniques will be requiredto discern the oligomerization processes
and the factors that regulate their
dynamics. Further, these techniques
would allow us to better understand the
role of endocytosis in synaptic transmis-
sion and perhaps whether recycling
endosomes represent a secondary level
of subunit-specific processing. These
issues are critical to resolve because,
unlike in politics, ‘‘flip-flopping’’ appears
to be a good thing in neurons.
ACKNOWLEDGMENTS
The authors were supported by grants from NIH
and the MSTP (C.L.S.).
REFERENCES
Anggono, V., and Huganir, R.L. (2012). Curr. Opin.
Neurobiol. 22, 461–469.
Cull-Candy, S., Kelly, L., and Farrant, M. (2006).
Curr. Opin. Neurobiol. 16, 288–297.
Dingledine, R., Borges, K., Bowie, D., and Trayne-
lis, S.F. (1999). Pharmacol. Rev. 51, 7–61.
Greger, I.H., Khatri, L., and Ziff, E.B. (2002). Neuron
34, 759–772.
Hoze, N., Nair, D., Hosy, E., Sieben, C., Manley, S.,
Herrmann, A., Sibarita, J.B., Choquet, D., and
Holcman, D. (2012). Proc. Natl. Acad. Sci. USA
109, 17052–17057.Neuron 76,Jackson, A.C., and Nicoll, R.A. (2011). Neuron 70,
178–199.
Kumar, J., and Mayer, M.L. (2012). Annu. Rev.
Physiol. Published online September 4, 2012.
http://dx.doi.org/10.1146/annurev-physiol-030212-
183711.
Lu, W., and Roche, K.W. (2012). Curr. Opin. Neuro-
biol. 22, 470–479.
Lu, W., Shi, Y., Jackson, A.C., Bjorgan, K., During,
M.J., Sprengel, R., Seeburg, P.H., and Nicoll, R.A.
(2009). Neuron 62, 254–268.
Penn, A.C., Balik, A., Wozny, C., Cais, O., and
Greger, I.H. (2012). Neuron 76, this issue,
503–510.
Salussolia, C.L., Corrales, A., Talukder, I., Kazi, R.,
Akgul, G., Bowen, M., andWollmuth, L.P. (2011). J.
Biol. Chem. 286, 40205–40218.
Sommer, B., Keina¨nen, K., Verdoorn, T.A., Wisden,
W., Burnashev, N., Herb, A., Ko¨hler, M., Takagi, T.,
Sakmann, B., and Seeburg, P.H. (1990). Science
249, 1580–1585.
Sukumaran, M., Penn, A.C., and Greger, I.H.
(2012). Adv. Exp. Med. Biol. 970, 241–264.
Traynelis, S.F., Wollmuth, L.P., McBain, C.J., Men-
niti, F.S., Vance, K.M., Ogden, K.K., Hansen, K.B.,
Yuan, H., Myers, S.J., and Dingledine, R. (2010).
Pharmacol. Rev. 62, 405–496.
Turrigiano, G. (2012). Cold Spring Harb. Perspect.
Biol. 4, a005736.Charting a Course toward
an Understanding of SchizophreniaJoshua A. Gordon1,2,* and Holly Moore1,2
1Department of Psychiatry, Columbia University, New York, NY 10032, USA
2Division of Integrative Neuroscience, New York State Psychiatric Institute, New York, NY 10032, USA
*Correspondence: jg343@columbia.edu
http://dx.doi.org/10.1016/j.neuron.2012.10.023
Clinical studies suggest a correlation between sleep disturbances and cognitive dysfunction in patients with
schizophrenia, though the neurobiological basis of this association is unclear. In this issue of Neuron, a new
study by Phillips et al. (2012) describes deficits in the neural oscillations underlying sleep in a neurodevelop-
mental model of the disorder.Understanding the neurobiology of
schizophrenia is like charting a course
on a map—a map, that is, with a very
fuzzy idea of a destination, many potential
starting points, and far too many opinionsabout waypoints to visit in between
(Figure 1). The destination is the disorder
itself, rendered fuzzy by its profound
heterogeneity. For starting points, we
have its myriad potential causal factors,be they genes such as DISC1 or the
22q11.2 microdeletion, or early environ-
mental factors such as prenatal infec-
tion or malnutrition. The waypoints are
the equally varied pathophysiologicalNovember 8, 2012 ª2012 Elsevier Inc. 465
Figure 1. Charting a Course through the Morass of Schizophrenia
The heterogeneous nature of schizophrenia requires careful mapping of the relationships between causal
factors, pathophysiology, and symptoms. Among the many possible pathways, the ones suggested from
the results of Phillips et al. (2012) are highlighted in orange. In a neurodevelopmental disruption model,
they find deficits in long-range connectivity, sleep, and neural oscillations. Dotted lines represent testable
hypotheses regarding how these deficits may relate to each other and to cognitive dysfunction. In gray are
a subset of representative findings and hypothetical pathways that arise from other studies mentioned in
the text; these are but a few of many possible starts, waypoints, destinations, and pathways that could be
included on such a map. General scheme adapted from discussions at the Ernst Strungmann Forum on
Schizophrenia: Evolution and Synthesis, held in Frankfurt, Germany in July, 2012.
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Previewstheories, ranging from too much dopa-
mine to too little GABA and encompass-
ing just about everything in between.
In such a morass of a landscape, how
is a neuroscientist supposed to navi-
gate toward a better understanding of
schizophrenia?
We would argue that one needs first to
fill in the map—to sketch out which paths
lead to which destinations. Or to put it in
into scientific terms, one needs to make
and test hypotheses about how specific
causes lead to specific pathophysiol-
ogies; how specific pathophysiologies
lead to the symptoms of schizophrenia
and how these causes and pathophysiol-
ogies interact. This approach is, at is
sounds, a tremendous endeavor, but it is
necessary in order to populate our map
with valid pathways. And it just may
yield novel ways of thinking about
schizophrenia.
The paper by Phillips et al. (2012) in this
issue of Neuron does just that. It is
inspired by the clinical observation that
sleep patterns and the oscillatory neural
activity that typically accompanies sleep,
are disrupted in patients with schizo-
phrenia (Manoach and Stickgold, 2009).
Here then is a destination potentially con-
nected to a couple of waypoints. Perhaps466 Neuron 76, November 8, 2012 ª2012 Elsthese oscillatory and sleep disturbances
reflect an underlying neurobiological
dysfunction that could be dissected in
detail. As a starting point, the authors
chose to examine, using the MAM-E17
rat model, whether and how a disruption
of embryonic brain development might
lead to sleep disturbances and to further
examine the neural activity patterns
underlying these disturbances.
The MAM-E17 model evolved from
early studies on the effect of methylazox-
ymethanol (MAM), a naturally occurring
nucleic acid alkylating agent (Smith,
1966), on the developing brain. An early
study (Haddad et al., 1969) showed that
administration of MAM to pregnant rat
dams resulted in alterations in brain
structure and behavior in the offspring,
including microcephaly, hyperactivity,
and apparent learning deficits. Although
not entirely selective, MAM can be used
to target specific circuits through onto-
logical timing of the exposure (Rice
and Barone, 2000). Offspring of dams
exposed to appropriate doses of MAM
at embryonic day 17 (E17) exhibit neuro-
pathological, neurochemical, and behav-
ioral phenotypes that appear analogous,
in some cases homologous, to pheno-
types reported in schizophrenia (seeevier Inc.Lodge and Grace, 2009 for review).
MAM-E17 leads to an apparent reduc-
tion in neuropil in frontal and temporal
cortex and a decrease in the density of
parvalbumin-expressing (PV+) cortical
interneurons, two histopathological find-
ings reported in schizophrenia (Lodge
and Grace, 2009). Finally, adult MAM
E17 offspring show a schizophrenia-
relevant array of cognitive deficits in-
cluding deficits in sensorimotor gating,
latent inhibition, and cognitive flexibility
(Featherstone et al., 2007; Lodge and
Grace, 2009; Moore et al., 2006). These
and other findings support the use of
this model to examine plausible, mecha-
nistic links between neural and behavioral
phenotypes of relevance to schizo-
phrenia. Along this line, Phillips et al.
(2012) exemplifies a novel and powerful
approach.
Taking the MAM-E17 model as a start-
ing point, the authors examine it from
a novel perspective—that perhaps the
cognitive deficits observed in this model
(and, by extension, in schizophrenia)
might be due to disruptions in sleep. To
this end, they recorded cranial EEG and
behavior from MAM-E17 offspring and
controls, monitoring them around the
clock. While the MAM-E17 rats showed
the normal circadian rhythms, the amount
of non-REM sleep was significantly
reduced. Moreover, the EEG record-
ings demonstrated decreases in delta-
frequency power in the posterior cranial
site, due primarily to a decrease in the
density of delta waves. Comparing
activity across anterior and posterior
EEG sites, the authors found decreased
delta-frequency coherence and de-
creased synchrony between anterior
high-frequency sleep spindles and poste-
rior delta waves. Taken together, the EEG
findings are consistent with deficits in
long-range coordination of the oscilla-
tions that define non-REM sleep.
Of course, the strength of an animal
model is the ability to move beyond EEG
recordings to examine specific circuits
within the brain. Accordingly, combined
hippocampal and medial prefrontal
cortical depth recordings uncovered defi-
cits in the synchrony that normally occurs
within this circuit during non-REM sleep.
Specifically, hippocampal ripples (150–
250 Hz bursts in the local field potential)
are typically tightly correlated with the
Neuron
Previewsoccurrence of spindles in the prefrontal
cortex (Siapas and Wilson, 1998). Phillips
et al. (2012) report a decrease in the
synchronization of spindles and ripples
in MAM-E17 rats, as well as a decrease
in the synchrony between prefrontal
cortical and hippocampal single unit firing
patterns. Simply put, MAM-E17 rats show
a loss of limbic-cortical synchrony.
How might these findings relate to
schizophrenia symptomatology? The
authors suggest that this disruption in
limbic-cortical interactions disorganizes
the normally tightly orchestrated slow
wave and ripple/spindle oscillations,
reducing the extent of non-REM sleep.
Referring to the substantial literature
implicating these oscillatory sleep
phenomena in cognitive processes such
as consolidation, they then speculate
that such a disruption may contribute to
the cognitive dysfunction seen in the
disease. While the current manuscript
does not directly compare disruptions in
cognition and sleep in the MAM-E17
rats, the authors note that clinical studies
suggest a correlation between reductions
in non-REM sleep and cognitive perfor-
mance in patients with schizophrenia
(Manoach and Stickgold, 2009).
From a mechanistic standpoint, the
findings described here are intriguing, as
they provide a framework for future
studies into the specific mechanisms by
which disruptions in neurodevelopment
can alter the fidelity of sleep-related
neural oscillations. In their discussion,
Phillips et al. (2012) point to one possible
mechanism: PV+ interneurons. The
apparent density of these interneurons is
decreased in both schizophrenia patients
and MAM-E17 rats. Moreover, they have
been implicated in the generation of
cortical oscillations of various frequencies
(Gonzalez-Burgos et al., 2011). Exploring
the role of PV+ interneurons in delta-,
ripple-, and spindle-frequency oscilla-
tions and their coordination during non-
REM sleep would be a promising future
endeavor.
Another potential mechanistic path to
explore would be the role of long-range
connections in the observed physiolog-
ical and behavioral phenotypes. Indeed,
while the authors demonstrate some
disruption of local processes, such as
a subtle decrease in spindle density, the
most striking findings relate to synchronyacross regions. The decreased delta-
frequency coherence between anterior
and posterior EEG sites, decreased
posterior delta power, and diminished
coordination between anterior spindles
and posterior delta waves are each
consistent with diminished fidelity in the
propagation of activity across distant
cortical sites. Similarly, the decreased
synchrony between hippocampal and
prefrontal neural activity at both the oscil-
latory activity and single unit levels
suggests an impairment in long-range
functional connectivity between these
structures.
The hypothesis that long-range con-
nections are impaired in schizophrenia is
an idea that has been gaining traction,
most recently with the advent of func-
tional and structural imaging techniques
capable of examining connectivity in the
intact human brain (Pettersson-Yeo
et al., 2011). A key challenge has been
to relate such findings to specific etiolog-
ical causes—to chart out the possible
courses on the map. Here, progress is
being made in a variety of ways. Deficits
in connectivity have been linked to
specific genetic mutations through both
animal (Sigurdsson et al., 2010) and
human (Esslinger et al., 2009) studies, as
well as to an animal model of an environ-
mental risk factor (Dickerson et al.,
2010). The current study extends these
findings to demonstrate deficits in func-
tional connectivity in a toxin-inducemodel
of a neurodevelopmental deficit that, as
noted above, shares several neuropatho-
logical, neurochemical, and behavioral
features with schizophrenia.
Establishing the relevance of these
results from the MAM-E17 rat model to
the neurobiology of schizophrenia will
require further work. Beyond clarifying
the mechanistic details, one key next
step will be to examine sleep and sleep-
related oscillations in animal models
based on specific, known etiological
factors, such as the 22q11 microdeletion
or maternal infection models. Demon-
strating similar findings in etiologically-
relevant models will provide convergent
validity, helping fill in the map of potential
explanatory pathways. In addition, stud-
ies in such models will help address a
principle limitation of the MAM-E17
model, which, though it shares important
features with schizophrenia, does notNeuron 76,mimic any known specific cause of the
disease.
In the end, however, the utility of a
model is not a function of how many
features it shares with a disease, but
rather how well it can be exploited to
generate and test hypotheses about how
that disease arises and manifests in the
brain. The Phillips et al. (2012) study sug-
gests that neurodevelopmental distur-
bances can give rise to disturbances in
the structure and quantity of non-REM
sleep. It inspires the novel hypothesis
that such disturbances might lead to the
impaired cognitive function observed in
schizophrenia. And it suggests specific,
testable hypotheses for circuit-based
mechanisms that might generate these
disturbances.REFERENCES
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